Addressing four measures of disease progression in relapsing MS could help preserve physical and cognitive function.
Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
NIBR scientists do mini-sabbaticals with clinical researchers at other sites. Learn how they refresh their skills and boost scientific research.
Induced pluripotent stem cells offer neuroscientist at NIBR a way to study autism. Learn how a brain-in-a-dish is created for drug discovery.
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Genetics often underlies mental health. Learn how NIBR researchers are trying to identify associated drug targets to improve the conditions.
Ricardo Dolmetsch was living the scientific dream by his mid-30s. Already a professor at Stanford University, he was running a successful lab, winning grants and receiving recognition for work in an area of neuroscience called calcium channel signaling. But then his son was diagnosed with autism.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.